Literature DB >> 22361828

Breadth of the CD4+ T cell response to Anaplasma marginale VirB9-1, VirB9-2 and VirB10 and MHC class II DR and DQ restriction elements.

Kaitlyn Morse1, Junzo Norimine, Jayne C Hope, Wendy C Brown.   

Abstract

MHC class II molecules influence antigen-specific CD4+ T lymphocyte responses primed by immunization and infection. CD4+ T cell responses are important for controlling infection by many bacterial pathogens including Anaplasma marginale and are observed in cattle immunized with the protective A. marginale outer membrane (OM) vaccine. Immunogenic proteins that comprise the protective OM vaccine include type IV secretion system (T4SS) proteins VirB9-1, VirB9-2 and VirB10, candidates for inclusion in a multiepitope vaccine. Our goal was to determine the breadth of the VirB9-1, VirB9-2 and VirB10 T cell response and MHC class II restriction elements in six cattle with different MHC class II haplotypes defined by DRB3, DQA and DQB allele combinations for each animal. Overlapping peptides spanning each T4SS protein were tested in T cell proliferation assays with autologous antigen-presenting cells (APC) and artificial APC expressing combinations of bovine DR and DQ molecules. Twenty immunostimulatory peptides were identified; three representing two or more epitopes in VirB9-1, ten representing eight or more epitopes in VirB9-2 and seven representing seven or more epitopes in VirB10. Of the eight DRA/DRB3 molecules, four presented 15 peptides, which was biased as DRA/DRB3*1201 presented ten and DRA/DRB3*1101 presented four peptides. Four DQA/DQB molecules composed of two intrahaplotype and two interhaplotype pairs presented seven peptides, of which five were uniquely presented by DQ molecules. In addition, three functional mixed isotype (DQA/DRB3) restriction elements were identified. The immunogenicity and broad MHC class II presentation of multiple VirB9-1, VirB9-2 and VirB10 peptide epitopes justify their testing as a multiepitope vaccine against A. marginale.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22361828      PMCID: PMC3372765          DOI: 10.1007/s00251-012-0606-4

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  42 in total

Review 1.  Antigenic variation in the persistence and transmission of the ehrlichia Anaplasma marginale.

Authors:  G H Palmer; W C Brown; F R Rurangirwa
Journal:  Microbes Infect       Date:  2000-02       Impact factor: 2.700

2.  Selection of T-cell epitopes from foot-and-mouth disease virus reflects the binding affinity to different cattle MHC class II molecules.

Authors:  A Haghparast; M H Wauben; M C Grosfeld-Stulemeyer; P van Kooten; E J Hensen
Journal:  Immunogenetics       Date:  2000-07       Impact factor: 2.846

3.  Immunodominant epitopes in Babesia bovis rhoptry-associated protein 1 that elicit memory CD4(+)-T-lymphocyte responses in B. bovis-immune individuals are located in the amino-terminal domain.

Authors:  Junzo Norimine; Carlos E Suarez; Terry F McElwain; Monica Florin-Christensen; Wendy C Brown
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

4.  Immunology. The ins and outs of antigen processing and presentation.

Authors:  R N Germain
Journal:  Nature       Date:  1986 Aug 21-27       Impact factor: 49.962

5.  Major histocompatibility complex class II DR-restricted memory CD4(+) T lymphocytes recognize conserved immunodominant epitopes of Anaplasma marginale major surface protein 1a.

Authors:  Wendy C Brown; Travis C McGuire; Waithaka Mwangi; Kimberly A Kegerreis; Henriette Macmillan; Harris A Lewin; Guy H Palmer
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

6.  Bovine leukocyte antigen major histocompatibility complex class II DRB3*2703 and DRB3*1501 alleles are associated with variation in levels of protection against Theileria parva challenge following immunization with the sporozoite p67 antigen.

Authors:  Keith T Ballingall; Anthony Luyai; G John Rowlands; Jill Sales; Anthony J Musoke; Subash P Morzaria; Declan J McKeever
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

7.  The diversity of bovine MHC class II DRB3 genes in Japanese Black, Japanese Shorthorn, Jersey and Holstein cattle in Japan.

Authors:  S Takeshima; N Saitou; M Morita; H Inoko; Y Aida
Journal:  Gene       Date:  2003-10-16       Impact factor: 3.688

8.  Unexpected expression of a unique mixed-isotype class II MHC molecule by transfected L-cells.

Authors:  R N Germain; H Quill
Journal:  Nature       Date:  1986 Mar 6-12       Impact factor: 49.962

9.  Characterization of lymphocyte subpopulations and major histocompatibility complex haplotypes of mastitis-resistant and susceptible cows.

Authors:  Yong Ho Park; Yi Seok Joo; Joo Youn Park; Jin San Moon; So Hyun Kim; Nam Hoon Kwon; Jong Sam Ahn; William C Davis; Christopher J Davies
Journal:  J Vet Sci       Date:  2004-03       Impact factor: 1.672

10.  Biological effect of varying peptide binding affinity to the BoLA-DRB3*2703 allele.

Authors:  Zahra Alizadeh; Niel Karrow; Bonnie A Mallard
Journal:  Genet Sel Evol       Date:  2003       Impact factor: 4.297

View more
  10 in total

Review 1.  Vaccination against Bacterial Infections: Challenges, Progress, and New Approaches with a Focus on Intracellular Bacteria.

Authors:  Anke Osterloh
Journal:  Vaccines (Basel)       Date:  2022-05-10

2.  Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like Disease.

Authors:  Nathali Kaushansky; Miriam Eisenstein; Sigalit Boura-Halfon; Bjarke Endel Hansen; Claus Henrik Nielsen; Ron Milo; Gabriel Zeilig; Hans Lassmann; Daniel M Altmann; Avraham Ben-Nun
Journal:  J Biol Chem       Date:  2015-04-24       Impact factor: 5.157

3.  Global transcriptional analysis reveals surface remodeling of Anaplasma marginale in the tick vector.

Authors:  G Kenitra Hammac; Sebastián Aguilar Pierlé; Xiaoya Cheng; Glen A Scoles; Kelly A Brayton
Journal:  Parasit Vectors       Date:  2014-04-21       Impact factor: 3.876

4.  Nanoparticle-Based Delivery of Anaplasma marginale Membrane Proteins; VirB9-1 and VirB10 Produced in the Pichia pastoris Expression System.

Authors:  Bing Zhang; Antonio S Cavallaro; Karishma T Mody; Jun Zhang; James R Deringer; Wendy C Brown; Timothy J Mahony; Chengzhong Yu; Neena Mitter
Journal:  Nanomaterials (Basel)       Date:  2016-11-05       Impact factor: 5.076

5.  VirB10 vaccination for protection against Anaplasma phagocytophilum.

Authors:  Francy L Crosby; Anna M Lundgren; Carol Hoffman; David W Pascual; Anthony F Barbet
Journal:  BMC Microbiol       Date:  2018-12-18       Impact factor: 3.605

6.  Structure of the type IV secretion system in different strains of Anaplasma phagocytophilum.

Authors:  Basima Al-Khedery; Anna M Lundgren; Snorre Stuen; Erik G Granquist; Ulrike G Munderloh; Curtis M Nelson; A Rick Alleman; Suman M Mahan; Anthony F Barbet
Journal:  BMC Genomics       Date:  2012-11-29       Impact factor: 3.969

7.  A genome-wide association study of immune response traits in Canadian Holstein cattle.

Authors:  Kathleen A Thompson-Crispi; Mehdi Sargolzaei; Ricardo Ventura; Mohammed Abo-Ismail; Filippo Miglior; Flavio Schenkel; Bonnie A Mallard
Journal:  BMC Genomics       Date:  2014-07-04       Impact factor: 3.969

8.  Immunogenicity of Outer Membrane Proteins VirB9-1 and VirB9-2, a Novel Nanovaccine against Anaplasma marginale.

Authors:  Liang Zhao; Donna Mahony; Antonino S Cavallaro; Bing Zhang; Jun Zhang; James R Deringer; Chun-Xia Zhao; Wendy C Brown; Chengzhong Yu; Neena Mitter; Anton P J Middelberg
Journal:  PLoS One       Date:  2016-04-26       Impact factor: 3.240

Review 9.  Anaplasma marginale: Diversity, Virulence, and Vaccine Landscape through a Genomics Approach.

Authors:  Rosa Estela Quiroz-Castañeda; Itzel Amaro-Estrada; Sergio Darío Rodríguez-Camarillo
Journal:  Biomed Res Int       Date:  2016-08-17       Impact factor: 3.411

10.  A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge.

Authors:  Macarena Sarli; María B Novoa; Matilde N Mazzucco; Marcelo L Signorini; Ignacio E Echaide; Susana T de Echaide; María E Primo
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.